Skip to main content
. 2020 Jun 28;60(12):1585–1597. doi: 10.1002/jcph.1682

Table 3.

ADC and MMAE Final Model Parameters

ADC MMAE
Parameter Population Mean (SE%) %CV IIV (Shrinkage) Population Mean (SE%) %CV IIV (Shrinkage)
Clearance, L/h 0.05 (10.3%) 53.8 (4.2%) 0.604 (8.7%) 53.7 (11.2%)
Central volume (V1), L 3.71 (3.2%) 15.1 (10.9%) 10.5 (7.1%) 75.2 (16.3%)
Binding rate constant (Kd 1/h) 0.00374 (12.3%) 172.6 (13.6%)
Intercompartmental clearance (Q2), L/h 0.02 (17.3%) 63.7 (24.1%)
13.1 (9.8%)
Peripheral volume (V2), L 206 (16.6%)
22.2 (10.4%) 63.6 (15.5%)
Fraction metabolized 1 FIX
Intercompartmental clearance (Q3), L/h 0.08 (5.0%)
ADC to MMAE conversion rate (ALFM 1/h) 2.68 (1.9%)
Peripheral volume (V3), L 5.0 (10.9%) 48.1 (10.1%)
Lag compartment rate constant (Klag 1/h) 15.3 (33.1%)
BSA on central volume (V1) 1.36 (8.6%)
1.22 (35.4%)
BSA on clearance 1.66 (17.8%)
ADA positive on clearance 1.82 (1.7%)
Albumin concentration on clearance −0.90 (10.4%)
Bilirubin on clearance 0.15 (13.1%)
AST on Kd −0.672 (11.3%)
BSA on Kd −3.35 (26.8%)
BSA on peripheral volume (V2), L 1.81 (22.2%)
BSA on peripheral volume (V3) 1.15 (24.6%)
Residual variability 28.6%CV (0.9%) 35.7%CV (0.8%CV)

ADA, antidrug antibody; ADC, antibody‐drug conjugate; ALFM, rate constant to describe the decline in direct conversion of ADC to MMAE following time after dose; AST, aspartate transaminase; BSA, body surface area; CV, coefficient of variation; IIV, interindividual variability; Kd, binding rate constant; Klag, lag compartment rate constant; MMAE, monomethyl auristatin E; Q2, intercompartmental clearance from compartment 1 to compartment 2; Q3, intercompartmental clearance from compartment 2 to 3; SE, standard error; V1, central volume of distribution; V2, first peripheral volume of distribution; V3, second peripheral volume of distribution; 1 FIX, value fixed to 1.